Metabolic control of arthritis: Switch pathways to treat

Science Translational Medicine

Volumn 8, Issue 331, 2016, Pages

  Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; METABOLIC REGULATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; TREATMENT PLANNING; CELL DIFFERENTIATION; METABOLISM;

ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; HUMANS; TH1 CELLS; TH17 CELLS;

EID: 84961802041     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf4953     Document Type: Review

References (9)

1. S. Y. Lunt, M. G. Vander Heiden, Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441-464 (2011).
2. Z. Yang, Y. Shen, H. Oishi, E. L. Matteson, L. Tian, J. J. Goronzy, C. M. Weyand, Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci. Transl. Med. 8, 331ra38 (2016).
3. A. Stincone, A. Prigione, T. Cramer, M. M. Wamelink, K. Campbell, E. Cheung, V. Olin-Sandoval, N. Grüning, A. Krüger, M. Tauqeer Alam, M. A. Keller, M. Breitenbach, K. M. Brindle, J. D. Rabinowitz, M. Ralser, The return of metabolism: Biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 90, 927-963 (2014).
4. Z. Yang, H. Fujii, S. V. Mohan, J. J. Goronzy, C. M. Weyand, Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J. Exp. Med. 210, 2119-2134 (2013).
5. A. Perl, Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat. Rev. Rheumatol. 9, 674-686 (2013).
6. Y. Yin, S. C. Choi, Z. Xu, D. J. Perry, H. Seay, B. P. Croker, E. S. Sobel, T. M. Brusko, L. Morel, Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7, 274ra18 (2015).
7. A. Perl, Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat. Rev. Rheumatol. 12, 169-182 (2016).
8. A. M. Campbell, M. Kashgarian, M. J. Shlomchik, NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med. 4, 157ra141 (2012).
9. V. A. Gerriets, R. J. Kishton, A. G. Nichols, A. N. Macintyre, M. Inoue, O. Ilkayeva, P. S. Winter, X. Liu, B. Priyadharshini, M. E. Slawinska, L. Haeberli, C. Huck, L. A. Turka, K. C. Wood, L. P. Hale, P. A. Smith, M. A. Schneider, N. J. MacIver, J. W. Locasale, C. B. Newgard, M. L. Shinohara, J. C. Rathmell, Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194-207 (2015).